Andreas Kerschbaumer

Medical University of Vienna

Austria

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

40%

Pharmacology

90%

Rheumatology

100%

Inflammatory Disease

70%

Targeted Therapy

60%

Anti-inflammatory Research

60%

Inflammatory Biology

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles20

Definition of rheumatoid arthritis flare based on SDAI and CDAI

Article Link

Year:

2024

Determination of the most appropriate ACR response definition for contemporary drug approval trials in rheumatoid arthritis

Article Link

Year:

2024

Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review

Article Link

Year:

2024

Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story

Article Link

Year:

2024

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

Article Link

Year:

2024

Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls

Article Link

Year:

2023

Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

Article Link

Year:

2023

Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review

Article Link

Year:

2023

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

Article Link

Year:

2023

Influence of active versus placebo control on treatment responses in randomised controlled trials in rheumatoid arthritis

Article Link

Year:

2023

Influence of active versus placebo control on treatment responses in randomised controlled trials in rheumatoid arthritis

Article Link

Year:

2023

Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

Article Link

Year:

2023

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

Article Link

Year:

2023

Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial

Article Link

Year:

2022

Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritis

Article Link

Year:

2022

A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases

Article Link

Year:

2022

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.

Article Link

Year:

2022

Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis

Article Link

Year:

2022

A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis.

Article Link

Year:

2021

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis.

Article Link

Year:

2021

Collaborators11

Gregor Bond

AUSTRIA

Angelo Ravelli

ITALY

Patrick Verschueren

Full Professor

Katholieke Universiteit Leuven

BELGIUM

Paul Studenic

Karolinska Institutet

SWEDEN

Renate Kain

Medical University of Vienna

AUSTRIA

Tanja Stamm

Medical University of Vienna

AUSTRIA

Tsutomu Takeuchi

Keio University School of Medicine

JAPAN

Christian Dejaco

ITALY

Daniel Mrak

Medical University of Vienna

AUSTRIA

Michael Bonelli

Medical University of Vienna

AUSTRIA

Frank Buttgereit

GERMANY

How do I reach out?

Meet Kite AI